Global New Drug Development : An Introduction

the light of increasing integration of company and academic approaches to drug development both sides can read this book... (and, therefore)... this book could not be more timely." Professor Mike Coleman , University of Aston, UK ( from his review of the final manuscript) [Publisher's Text]

909930 characters.